内科学(呼吸器)

研究成果

年別の研究成果 1997 2017 2018 2019 2020 2021 2022 2023 2023

• 360 Article
• 18 Review article
• 15 Comment/debate
• 13 Letter
• 7 その他
  • 2 Conference contribution
  • 2 Editorial
  • 2 Short survey
  • 1 Chapter

年別の研究成果

年別の研究成果

検索結果

• 2023

  Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis

  Okada, N., Yamamoto, Y., Oguma, T., Tanaka, J., Tomomatsu, K., Shiraishi, Y., Matsuse, H., Shimoda, T., Kimura, H., Watai, K., Harada, T., Fujita, Y., Obase, Y., Suzukawa, M., Suzuki, J., Takayanagi, N., Ishiguro, T., Masaki, K., Fukunaga, K. & Asano, K., 2023, (Accepted/In press) In: Allergy: European Journal of Allergy and Clinical Immunology.

  研究成果: Article › 査読

  Open Access

  • Allergic Bronchopulmonary Aspergillosis 100%
  • Asthma 44%
  • Mucus 11%
  • Fungal Structures 8%
  • Precipitins 7%

• Annexin A1 is a cell-intrinsic metalloregulator of zinc in human ILC2s

  Irie, M., Kabata, H., Sasahara, K., Kurihara, M., Shirasaki, Y., Kamatani, T., Baba, R., Matsusaka, M., Koga, S., Masaki, K., Miyata, J., Araki, Y., Kikawada, T., Kabe, Y., Suematsu, M., Yamagishi, M., Uemura, S., Moro, K. & Fukunaga, K., 2023 6月 27, In: Cell Reports. 42, 6, 112610.

  研究成果: Article › 査読

  Open Access

  • Annexin A1 100%
  • Zinc 64%
  • Metallothionein 16%
  • Genes 16%
  • Interleukin-13 15%

• Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study

  Hosoya, K., Komachi, T., Masaki, K., Suzaki, I., Saeki, H., Kanda, N., Nozaki, M., Kamide, Y., Matsuwaki, Y., Kobayashi, Y., Ogino, E., Osada, S. I., Usukura, N., Kurumagawa, T., Ninomia, J., Asako, M., Nakamoto, K., Yokoi, H., Ohyama, M., Tanese, K., & 4 othersKanzaki, S., Fukunaga, K., Ebisawa, M. & Okubo, K., 2023, In: Patient Preference and Adherence. 17, p. 861-872 12 p.

  研究成果: Article › 査読

  Open Access

  • dupilumab 100%
  • Injections 33%
  • Syringes 19%
  • pain 18%
  • regression analysis 16%

• Characteristics and clinical effectiveness of COVID-19 vaccination in hospitalized patients in Omicron-dominated epidemic wave – a nationwide study in Japan

  Tanaka, H., Chubachi, S., Asakura, T., Namkoong, H., Azekawa, S., Otake, S., Nakagawara, K., Fukushima, T., Lee, H., Watase, M., Sakurai, K., Kusumoto, T., Masaki, K., Kamata, H., Ishii, M., Hasegawa, N., Okada, Y., Koike, R., Kitagawa, Y., Kimura, A., & 5 othersImoto, S., Miyano, S., Ogawa, S., Kanai, T. & Fukunaga, K., 2023 7月, In: International Journal of Infectious Diseases. 132, p. 84-88 5 p.

  研究成果: Article › 査読

  Open Access

  • Epidemics 100%
  • Japan 95%
  • Vaccination 92%
  • Odds Ratio 59%
  • Confidence Intervals 55%

• Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID-19: Integrative analysis from the Japan COVID-19 task force

  The Japan COVID-19 Task Force, 2023 1月, In: Diabetes, Obesity and Metabolism. 25, 1, p. 144-155 12 p.

  研究成果: Article › 査読

  • Prediabetic State 100%
  • Coronavirus 97%
  • Advisory Committees 82%
  • Japan 64%
  • Odds Ratio 11%
  7 被引用数 (Scopus)

• Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma

  Kurihara, M., Kabata, H., Irie, M. & Fukunaga, K., 2023 1月, In: Allergology International. 72, 1, p. 24-30 7 p.

  研究成果: Review article › 査読

  Open Access

  • tezepelumab 100%
  • thymic stromal lymphopoietin 67%
  • Asthma 35%
  • Clinical Studies 31%
  • Antibodies 25%
  5 被引用数 (Scopus)

• Diagnostic significance of secondary bacteremia in patients with COVID-19

  The Japan COVID-19 Task Force, 2023 4月, In: Journal of Infection and Chemotherapy. 29, 4, p. 422-426 5 p.

  研究成果: Article › 査読

  Open Access

  • Coronavirus 100%
  • Bacteremia 81%
  • Bacterial Infections 37%
  • Coinfection 28%
  • Regression Analysis 13%
  2 被引用数 (Scopus)

• Differential impacts between fat mass index and fat-free mass index on patients with COPD

  Shimada, T., Chubachi, S., Otake, S., Sakurai, K., Sasaki, M., Iijima, H., Tanabe, N., Tanimura, K., Shimizu, K., Shirahata, T., Suzuki, M., Sato, S., Nakamura, H., Asano, K. & Fukunaga, K., 2023 10月, In: Respiratory Medicine. 217, 107346.

  研究成果: Article › 査読

  • Chronic Obstructive Pulmonary Disease 100%
  • Fats 84%
  • Emphysema 19%
  • Lung 18%
  • Quality of Life 16%

• Editorial: Heterogeneity of ILC2s

  Kabata, H. & Fukunaga, K., 2023, In: Frontiers in Immunology. 14, 1230569.

  研究成果: Editorial › 査読

  Open Access

• Executive summary: Japanese guidelines for adult asthma (JGL) 2021

  Niimi, A., Fukunaga, K., Taniguchi, M., Nakamura, Y., Tagaya, E., Horiguchi, T., Yokoyama, A., Yamaguchi, M. & Nagata, M., 2023 4月, In: Allergology International. 72, 2, p. 207-226 20 p.

  研究成果: Review article › 査読

  Open Access

  • Asthma 100%
  • Guidelines 82%
  • Muscarinic Antagonists 31%
  • Bronchial Thermoplasty 22%
  • Interleukin-5 Receptors 21%
  2 被引用数 (Scopus)

• Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma

  Ebisudani, T., Hamamoto, J., Togasaki, K., Mitsuishi, A., Sugihara, K., Shinozaki, T., Fukushima, T., Kawasaki, K., Seino, T., Oda, M., Hanyu, H., Toshimitsu, K., Emoto, K., Hayashi, Y., Asakura, K., Johnson, T. A., Terai, H., Ikemura, S., Kawada, I., Ishii, M., & 8 othersHishida, T., Asamura, H., Soejima, K., Nakagawa, H., Fujii, M., Fukunaga, K., Yasuda, H. & Sato, T., 2023 3月 28, In: Cell Reports. 42, 3, 112212.

  研究成果: Article › 査読

  Open Access

  • Organoids 100%
  • Adenocarcinoma of Lung 81%
  • Mutation 64%
  • Lung Neoplasms 60%
  • Genotype 54%
  1 被引用数 (Scopus)

• Healthcare costs for hospitalized COVID-19 patients in a Japanese university hospital: a cross-sectional study

  Uno, S., Goto, R., Honda, K., Tokuda, M., Kamata, H., Chubachi, S., Yamamoto, R., Sato, Y., Homma, K., Uchida, S., Namkoong, H., Uwamino, Y., Sasaki, J., Fukunaga, K. & Hasegawa, N., 2023 12月, In: Cost Effectiveness and Resource Allocation. 21, 1, 43.

  研究成果: Article › 査読

  Open Access

  • cross-sectional study 100%
  • Health Care Costs 89%
  • University Hospitals 78%
  • Healthcare 77%
  • Cross-Sectional Studies 65%

• Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force

  Japan COVID-19 Task Force, 2023 3月, In: International Journal of Infectious Diseases. 128, p. 121-127 7 p.

  研究成果: Article › 査読

  Open Access

  • Advisory Committees 100%
  • Chronic Obstructive Pulmonary Disease 83%
  • Japan 77%
  • Smoking 68%
  • Artificial Respiration 26%
  2 被引用数 (Scopus)

• Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

  The Japan COVID-19 Task Force, 2023 12月, In: BMC Pulmonary Medicine. 23, 1, 146.

  研究成果: Article › 査読

  Open Access

  • Coronavirus 100%
  • Bacterial Infections 74%
  • Respiratory Tract Infections 73%
  • Cohort Studies 54%
  • Retrospective Studies 53%
  1 被引用数 (Scopus)

• Interaction of BMI and respiratory status in obstructive sleep apnea, a cross-sectional COPD study

  Hashiguchi, M. H., Chubachi, S., Yamasawa, W., Otsuka, K., Harada, N., Miyao, N., Nakamura, H., Asano, K., Yamaguchi, K. & Fukunaga, K., 2023 12月, In: npj Primary Care Respiratory Medicine. 33, 1, 30.

  研究成果: Article › 査読

  Open Access

  • sleep 100%
  • Obstructive Sleep Apnea 94%
  • Chronic Obstructive Pulmonary Disease 82%
  • Body Mass Index 66%
  • event 45%

• Longitudinal significance of six-minute walk test in patients with nontuberculous mycobacterial pulmonary disease: an observational study

  Morita, A., Yagi, K., Asakura, T., Namkoong, H., Sato, Y., Ogawa, T., Kusumoto, T., Suzuki, S., Tanaka, H., Lee, H., Okamori, S., Azekawa, S., Nakagawara, K., Kaji, M., Nagao, G., Funatsu, Y., Kimizuka, Y., Kamata, H., Nishimura, T., Ishii, M., & 2 othersFukunaga, K. & Hasegawa, N., 2023 12月, In: BMC Pulmonary Medicine. 23, 1, 247.

  研究成果: Article › 査読

  Open Access

  • Walk Test 100%
  • Lung Diseases 74%
  • Observational Studies 64%
  • Respiratory Function Tests 46%
  • C-Reactive Protein 24%

• Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review

  Kaji, M., Namkoong, H., Nagao, G., Azekawa, S., Nakagawara, K., Tanaka, H., Morita, A., Asakura, T., Kamata, H., Uwamino, Y., Yoshida, M., Fukunaga, K. & Hasegawa, N., 2023, In: Infection and Drug Resistance. 16, p. 3955-3963 9 p.

  研究成果: Article › 査読

  Open Access

  • Nontuberculous Mycobacterium Infections 100%
  • Nontuberculous Mycobacteria 42%
  • Mycobacterium Infections 35%
  • Sputum 25%
  • Mycobacterium abscessus 19%

• Observation of peripheral airways using ultra-thin fiberscope

  Kinoshita, T., Terai, H., Ikemura, S., Takada, N., Fukui, T., Irie, H., Miyazawa, R., Funatsu, Y., Okamura, T., Koh, H., Yamamoto, T., Shigematsu, R., Ohgino, K. & Oka, K., 2023 9月, In: Respirology. 28, 9, p. 881-884 4 p.

  研究成果: Letter › 査読

  Open Access

• Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study

  Ishikawa, E., Yokoyama, Y., Chishima, H., Kasai, H., Kuniyoshi, O., Kimura, M., Hakamata, J., Nakada, H., Suehiro, N., Nakaya, N., Nakajima, H., Ikemura, S., Kawada, I., Yasuda, H., Terai, H., Jibiki, A., Kawazoe, H., Soejima, K., Muramatsu, H., Suzuki, S., & 1 othersNakamura, T., 2023 2月, In: Investigational new drugs. 41, 1, p. 122-133 12 p.

  研究成果: Article › 査読

  Open Access

  • osimertinib 100%
  • Pharmacogenetics 71%
  • Non-Small Cell Lung Carcinoma 56%
  • Observational Studies 48%
  • Pharmacokinetics 47%
  1 被引用数 (Scopus)

• Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents

  the Keio Donner Project, 2023 6月 16, In: iScience. 26, 6, 106955.

  研究成果: Article › 査読

  Open Access

  • SARS Virus 100%
  • Broadly Neutralizing Antibodies 95%
  • Neutralizing Antibodies 67%
  • B-Lymphocytes 52%
  • Antigens 43%

• Real-world effects of once-daily inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) and long-acting muscarinic antagonist (umeclidinium) on lung function tests of asthma patients in Japan

  Umeda, A., Shimada, H., Yamane, T., Mochizuki, T., Inoue, Y., Tsushima, K., Miyagawa, K., Mochida, A., Takeda, H., Okada, Y., Masaki, K., Matsusaka, M. & Fukunaga, K., 2023, In: Frontiers in Physiology. 14, 1131949.

  研究成果: Article › 査読

  Open Access

  • GSK573719 100%
  • vilanterol 95%
  • fluticasone furoate 94%
  • Muscarinic Antagonists 67%
  • Respiratory Function Tests 61%

• Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study

  Fukunaga, K., Tagaya, E., Ishida, M., Sunaga, Y., Koshiba, R. & Yokoyama, A., 2023, (Accepted/In press) In: Allergology International.

  研究成果: Article › 査読

  Open Access

  • dupilumab 100%
  • Japan 48%
  • Asthma 45%
  • Adrenal Cortex Hormones 41%
  • Hospitalization 16%

• Relationships of computed tomography-based small vessel indices of the lungs with ventilation heterogeneity and high transfer coefficients in non-smokers with asthma

  Hi-CARAT investigators, 2023, In: Frontiers in Physiology. 14, 1137603.

  研究成果: Article › 査読

  Open Access

  • Total Lung Capacity 100%
  • Ventilation 79%
  • Smokers 76%
  • Asthma 69%
  • Tomography 61%

• Risk factors for poor adherence to inhaled corticosteroid therapy in patients with moderate to severe asthma

  Masaki, K., Miyata, J., Kamatani, T., Tanosaki, T., Mochimaru, T., Kabata, H., Suzuki, Y., Asano, K., Betsuyaku, T. & Fukunaga, K., 2023 6月 1, In: Asian Pacific Journal of Allergy and Immunology. 41, 2, p. 113-120 8 p.

  研究成果: Article › 査読

  Open Access

  • Adrenal Cortex Hormones 100%
  • Asthma 96%
  • Therapeutics 20%
  • Japan 17%
  • Medicine 15%
  4 被引用数 (Scopus)

• Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19

  Azekawa, S., Chubachi, S., Asakura, T., Namkoong, H., Sato, Y., Dahiro, R., Lee, H., Tanaka, H., Otake, S., Nakagawara, K., Fukushima, T., Watase, M., Sakurai, K., Kusumoto, T., Masaki, K., Kamata, H., Ishii, M., Hasegawa, N., Okada, Y., Koike, R., & 7 othersKitagawa, Y., Kimura, A., Imoto, S., Miyano, S., Ogawa, S., Kanai, T. & Fukunaga, K., 2023 5月 25, In: BMJ Open Respiratory Research. 10, 1

  研究成果: Article › 査読

  Open Access

  • Mucin-1 100%
  • Serum 35%
  • Regression Analysis 10%
  • Logistic Models 10%
  • Biomarkers 10%

• Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity

  Japan COVID-19 Task Force, 2023 5月, In: Nature genetics. 55, 5, p. 753-767 15 p.

  研究成果: Article › 査読

  Open Access

  • Single-Cell Analysis 100%
  • Coronavirus 93%
  • Monocytes 48%
  • B-Lymphocytes 12%
  • Coronavirus Infections 11%
  2 被引用数 (Scopus)

• Successful Steroid Treatment of Pembrolizumab-induced Agranulocytosis That Developed after Splenectomy in a Patient with Non-small-cell Lung Cancer

  Okuzumi, S., Kamata, H., Emoto, K., Shimizu, T., Otake, S., Irie, H., Chubachi, S., Ikemura, S., Yasuda, H. & Fukunaga, K., 2023, In: Internal Medicine. 62, 14, p. 2113-2121 9 p.

  研究成果: Article › 査読

  Open Access

  • pembrolizumab 100%
  • Agranulocytosis 91%
  • Splenectomy 76%
  • Non-Small Cell Lung Carcinoma 63%
  • Steroids 53%

• The burden of systemic corticosteroid use in asthma management in Asia

  Dhar, R., Rhee, C. K., Perng, D. W., Fukunaga, K., Ip, M. S. M., Juthong, S., Koh, M. S., Li, J., Sharma, S. & Wiyono, W. H., 2023 8月, In: Respirology. 28, 8, p. 744-757 14 p.

  研究成果: Review article › 査読

  Open Access

  • Adrenal Cortex Hormones 100%
  • Asthma 96%
  • Organizational Policy 25%
  • Treatment Adherence and Compliance 20%
  • Type 2 Diabetes Mellitus 13%
  1 被引用数 (Scopus)

• Time-dependent cell-state selection identifies transiently expressed genes regulating ILC2 activation

  Tanaka, Y., Yamagishi, M., Motomura, Y., Kamatani, T., Oguchi, Y., Suzuki, N., Kiniwa, T., Kabata, H., Irie, M., Tsunoda, T., Miya, F., Goda, K., Ohara, O., Funatsu, T., Fukunaga, K., Moro, K., Uemura, S. & Shirasaki, Y., 2023 12月, In: Communications biology. 6, 1, 915.

  研究成果: Article › 査読

  Open Access

  • Transition State 100%
  • Genes 49%
  • genes 42%
  • cells 38%
  • transcriptomics 30%

• TSLP による自然免疫と獲得免疫の制御メカニズム

  Kabata, H., 2023, In: Japanese Journal of Allergology. 72, 5, p. 443-447 5 p.

  研究成果: Review article › 査読

• Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19

  The Japan COVID-19 Task Force, 2023 7月, In: Respiratory Investigation. 61, 4, p. 454-459 6 p.

  研究成果: Article › 査読

  • Neutrophils 100%
  • Oxygen 90%
  • Lymphocytes 88%
  • Area Under Curve 51%
  • Coronavirus 40%

• 喘息予防・管理ガイドライン 2021

  Fukunaga, K., 2023, In: Japanese Journal of Allergology. 71, 3, p. 214-219 6 p.

  研究成果: Article › 査読
• 2022

  A 70-Year-Old Woman With Long-Term Nonresolving Pneumonia

  Tomiyasu, S., Kabata, H., Emoto, K., Azekawa, S., Maeda, C., Masai, K., Yasuda, H. & Fukunaga, K., 2022 4月, In: Chest. 161, 4, p. e219-e223

  研究成果: Article › 査読

  Open Access

  • Pneumonia 100%
  • Tobacco Smoke Pollution 76%
  • Cough 59%
  • General Practitioners 57%
  • Smoking 44%

• Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system

  Ozawa, T., Namkoong, H., Takaya, R., Takahashi, Y., Fukunaga, K., Enoki, Y., Taguchi, K., Kizu, J., Matsumoto, K. & Hasegawa, N., 2022 12月, In: BMC infectious diseases. 22, 1, 580.

  研究成果: Article › 査読

  Open Access

  • Mycobacterium avium Complex 100%
  • Ethambutol 97%
  • Clarithromycin 77%
  • Drug-Related Side Effects and Adverse Reactions 70%
  • Rifampin 68%
  1 被引用数 (Scopus)

• An Inhalation Device With Inertial Measurement Unit for Monitoring Inhaler Technique

  Takano, S., Shimono, T., Masaki, K., Fukunaga, K., Kabata, H., Nishie, M., Ezaki, T., Nakada, H., Hakamata, J. & Hasegawa, A., 2022 8月 1, In: IEEE/ASME Transactions on Mechatronics. 27, 4, p. 2204-2211 8 p.

  研究成果: Article › 査読

  Open Access

  • Units of measurement 100%
  • Pulmonary diseases 60%
  • Monitoring 49%
  1 被引用数 (Scopus)

• Apixaban-Associated Diffuse Alveolar Hemorrhage in an Elderly Man with Multiple Complications

  Ozawa, T., Terai, H., Kajino, A., Otake, S., Saito, A., Nishie, M., Kishino, Y., Kamata, H., Hayashida, K., Ishii, M. & Fukunaga, K., 2022, In: American Journal of Case Reports. 23, 1, e937809.

  研究成果: Article › 査読

  • apixaban 100%
  • Anticoagulants 66%
  • Elderly 48%
  • Hemorrhage 46%
  • Hemosiderin 8%

• Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force

  Japan COVID-19 Task Force, 2022 12月 12, In: BMC infectious diseases. 22, 1, p. 935 1 p.

  研究成果: Article › 査読

  Open Access

  • Coronavirus 100%
  • Advisory Committees 84%
  • Japan 65%
  • Infections 37%
  • Erythema Infectiosum 21%
  7 被引用数 (Scopus)

• Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics

  The Japan COVID-19 Task Force, 2022 12月, In: BMC infectious diseases. 22, 1, 735.

  研究成果: Article › 査読

  Open Access

  • Advisory Committees 100%
  • Cluster Analysis 84%
  • Japan 77%
  • Dysgeusia 47%
  • Olfaction Disorders 44%
  1 被引用数 (Scopus)

• Clinical Utility of the Electrocardiographic P-Wave Axis in Patients with Chronic Obstructive Pulmonary Disease

  Otake, S., Chubachi, S., Nakayama, S., Sakurai, K., Irie, H., Hashiguchi, M., Itabashi, Y., Yamada, Y., Jinzaki, M., Murata, M., Nakamura, H., Asano, K. & Fukunaga, K., 2022 4月 1, In: Respiration. 101, 4, p. 345-352 8 p.

  研究成果: Article › 査読

  Open Access

  • Chronic Obstructive Pulmonary Disease 100%
  • Electrocardiography 30%
  • We 201 20%
  • Emphysema 14%
  • Forced Expiratory Volume 13%
  2 被引用数 (Scopus)

• Comparison of inspiratory and expiratory airway volumes and luminal areas among standing, sitting, and supine positions using upright and conventional CT

  Yamada, Y., Yamada, M., Chubachi, S., Yokoyama, Y., Matsuoka, S., Tanabe, A., Niijima, Y., Murata, M., Abe, T., Fukunaga, K. & Jinzaki, M., 2022 12月, In: Scientific reports. 12, 1, 21315.

  研究成果: Article › 査読

  Open Access

  • Standing Position 100%
  • Supine Position 85%
  • Sitting Position 80%
  • Respiratory Function Tests 57%
  • Tomography 52%

• Comparison of Lung, Lobe, and Airway Volumes between Supine and Upright Computed Tomography and Their Correlation with Pulmonary Function Test in Patients with Chronic Obstructive Pulmonary Disease

  Yamada, Y., Chubachi, S., Yamada, M., Yokoyama, Y., Tanabe, A., Matsuoka, S., Niijima, Y., Murata, M., Fukunaga, K. & Jinzaki, M., 2022 12月 1, In: Respiration. 101, 12, p. 1110-1120 11 p.

  研究成果: Article › 査読

  Open Access

  • Respiratory Function Tests 100%
  • Supine Position 85%
  • Standing Position 83%
  • Chronic Obstructive Pulmonary Disease 79%
  • Tomography 61%
  3 被引用数 (Scopus)

• Current overview of the role of neuropeptides in ILC2s and future directions

  Irie, M., Sasahara, K., Artis, D. & Kabata, H., 2022 7月, In: Allergology International. 71, 3, p. 294-300 7 p.

  研究成果: Review article › 査読

  Open Access

  • Neuropeptides 100%
  • Direction compound 70%
  • Calcitonin Gene-Related Peptide 57%
  • Vasoactive Intestinal Peptide 56%
  • Adaptive Immunity 49%
  4 被引用数 (Scopus)

• Development of Rheumatoid Arthritis in Cavitary Mycobacterium avium Pulmonary Disease: A Case Report of Successful Treatment with CTLA4-Ig (Abatacept)

  Tanaka, H., Asakura, T., Kikuchi, J., Ishii, M., Namkoong, H., Kaneko, Y., Fukunaga, K. & Hasegawa, N., 2022, In: Infection and Drug Resistance. 15, p. 91-97 7 p.

  研究成果: Article › 査読

  Open Access

  • Abatacept 100%
  • Mycobacterium avium 96%
  • Lung Diseases 63%
  • Rheumatoid Arthritis 58%
  • Bronchiectasis 28%

• Diagnostic Performance of Computed Tomography Imaging for COVID-19 in a Region with Low Disease Prevalence

  Lee, H., Suzuki, T., Okada, Y., Tanaka, H., Okamori, S., Kamata, H., Ishii, M., Jinzaki, M. & Fukunaga, K., 2022, In: Keio Journal of Medicine. 71, 1, p. 21-30 10 p.

  研究成果: Article › 査読

  Open Access

  • Coronavirus 100%
  • Tomography 54%
  • Decision Support Techniques 17%
  • Thorax 14%
  • Lung Diseases 12%
  2 被引用数 (Scopus)

• Differences in lung and lobe volumes between supine and upright computed tomography in patients with idiopathic lung fibrosis

  Chubachi, S., Okamori, S., Yamada, Y., Yamada, M., Yokoyama, Y., Niijima, Y., Kamata, H., Ishii, M., Fukunaga, K. & Jinzaki, M., 2022 12月, In: Scientific reports. 12, 1, 19408.

  研究成果: Article › 査読

  Open Access

  • Fibrosis 100%
  • Tomography 91%
  • Standing Position 72%
  • Lung 72%
  • Supine Position 62%

• DOCK2 is involved in the host genetics and biology of severe COVID-19

  The Biobank Japan Project, 2022 9月 22, In: Nature. 609, 7928, p. 754-760 7 p.

  研究成果: Article › 査読

  Open Access

  • Cytokinesis 100%
  • Genes 33%
  • SARS Virus 30%
  • 4-(3'-(2'-chlorophenyl)-2'-propen-1'-ylidene)-1-phenyl-3,5-pyrazolidinedione 24%
  • RNA Sequence Analysis 23%
  29 被引用数 (Scopus)

• Early chronic obstructive pulmonary disease: Associations of two spirometry criteria with clinical features

  Mochizuki, F., Tanabe, N., Iijima, H., Shimada, T., Shiraishi, Y., Maetani, T., Yamazaki, H., Shimizu, K., Suzuki, M., Chubachi, S., Ishikawa, H., Naito, T., Masuko, H., Sakamoto, T., Masuda, I., Sato, S., Hizawa, N. & Hirai, T., 2022 11月 1, In: Respiratory Medicine. 204, 107011.

  研究成果: Article › 査読

  • Spirometry 100%
  • Forced Expiratory Volume 97%
  • Chronic Obstructive Pulmonary Disease 80%
  • Vital Capacity 49%
  • Smokers 28%

• Early intubation and decreased in-hospital mortality in patients with coronavirus disease 2019

  on behalf of the J-RECOVER study group, 2022 12月, In: Critical Care. 26, 1, 124.

  研究成果: Article › 査読

  Open Access

  • Coronavirus 100%
  • Intubation 76%
  • Hospital Mortality 76%
  • Oxygen 9%
  • Hypoxia 7%
  6 被引用数 (Scopus)

• Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings

  Morita, A., Namkoong, H., Yagi, K., Asakura, T., Hosoya, M., Tanaka, H., Lee, H., Ogawa, T., Kusumoto, T., Azekawa, S., Nakagawara, K., Kamata, H., Ishii, M., Fukunaga, K., Ozawa, H. & Hasegawa, N., 2022, In: Infection and Drug Resistance. 15, p. 4001-4011 11 p.

  研究成果: Article › 査読

  Open Access

  • Mycobacterium avium Complex 100%
  • Amikacin 89%
  • Inhalation 70%
  • Lung Diseases 67%
  • Liposomes 54%
  3 被引用数 (Scopus)

• Effects of mild obesity on outcomes in Japanese patients with COVID-19: a nationwide consortium to investigate COVID-19 host genetics

  The Japan COVID-19 Task Force, 2022 12月, In: Nutrition and Diabetes. 12, 1, 38.

  研究成果: Article › 査読

  Open Access

  • Coronavirus 100%
  • Obesity 55%
  • Body Mass Index 41%
  • Odds Ratio 13%
  • Japan 11%
  4 被引用数 (Scopus)